DAVID PIERCE: Open Payments
NPI 1497765119 · HERKIMER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,295 in 118 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $754 · 2025 $2,295
Food & beverage: $2,295
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $548 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $395 |
| Janssen Pharmaceuticals, Inc | 14 | $331 |
| Otsuka America Pharmaceutical, Inc. | 11 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $177 |
| Axsome Therapeutics, Inc. | 6 | $127 |
| Alkermes, Inc. | 4 | $108 |
| Neurocrine BioSciences, Inc. | 5 | $101 |
| Vanda Pharmaceuticals Inc. | 6 | $95 |
| Teva Pharmaceuticals USA, Inc. | 4 | $87 |
Products named: VRAYLAR, CAPLYTA, SPRAVATO, REXULTI, TRINTELLIX, Auvelity, ARISTADA, INGREZZA.
Industry payments across NY — which companies pay providers there.
